Site search

Kidney transplant desensitisation study for people on waiting lists Research study

This study is testing a treatment to see if it can lower antibodies in people on the kidney transplant waiting list.

Residential In Reach Post Hospital Support

Our Residential In Reach Post Hospital Support service can help patients to safely transition from a hospital admission to a Residential Aged Care Home (RACH).

Atumelnant in adult participants with classic Congenital Adrenal Hyperplasia Research study

The purpose of this study is to evaluate the effect of a potential new treatment for Congenital Adrenal Hyperplasia (CAH) called atumelnant and compare it to placebo treatment.

The Elumina Study Research study

Almost 1 in 3 people diagnosed with depression – or Major Depressive Disorder (MDD) – do not notice an improvement in their symptoms after trying at least two of the antidepressant drugs available today. This is known as Treatment-Resistant Depression (TRD). The Elumina study is...

A clinical trial testing a new investigational medication for people living with Graves’ Disease Research study

The purpose of this study is to compare a potential new treatment with improved side effects compared to current therapies in people living with Graves’ Disease. 

ONWARDS-11 Study Research study

This research study aims to get more information on how a weekly insulin (insulin icodec) helps in reducing blood sugar compared to insulin glargine, an insulin taken once daily, in adults with type 1 diabetes, who are also taking a mealtime insulin (insulin aspart). 

The IMAGINATION study Research study

This study is for people with a kidney condition called IgA nephropathy (IgAN), especially those at risk of their condition getting worse.

The FORTE Study Research study

This study is to test the safety and effectiveness of FB102 in well-controlled coeliac disease (those on a strict gluten free diet) following a gluten consumption challenge.

The TRANSCEND study – testing a new medicine for kidney transplant rejection Research study

This study is testing a new medication called felzartamab for people who have received a kidney transplant and developed a type of rejection called late antibody-mediated rejection (AMR).